AbbVie Expands siRNA Portfolio with ADARx Partnership Valued at $335 Million Upfront

AbbVie Expands siRNA Portfolio with ADARx Partnership Valued at $335 Million Upfront

AbbVie Expands siRNA Portfolio with ADARx Partnership Valued at $335 Million Upfront